Ben Tre Pharmaceutical JSC (HOSE: DBT)

Market Cap	230.77B
Revenue (ttm)	828.64B
Net Income (ttm)	16.89B
Shares Out	18.61M
EPS (ttm)	948.29
PE Ratio	13.08
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,600
Open	12,400
Previous Close	12,250
Day's Range	12,400 - 12,400
52-Week Range	10,000 - 14,100
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About DBT

Ben Tre Pharmaceutical Joint Stock Company manufactures, distributes, and sells pharmaceutical products in Vietnam and internationally. The company offers drugs in injectable, infusion, pill, and lotion forms. The company provides products covering various therapeutic areas, including central nervous system, respiratory system, endocrinology, obstetrics and gynecology, anti-allergic, cardiovascular, antibiotics, anti-fungal, anti-viral, musculoskeletal, vitamins and minerals, digestive, hepatobiliary and urinary, pain relief, fever reducer, ant...

• Industry: Pharmaceutical Preparations
• Founded: 1963
• Employees: 566
• Stock Exchange: Ho Chi Minh Stock Exchange
• Ticker Symbol: DBT

Financial Performance

In 2019, DBT's revenue was 800.50 billion, a decrease of -1.16% compared to the previous year's 809.91 billion. Earnings were 21.40 billion, an increase of 5.95%.